Sissel Rodahl
Corporate Officer/Principal at GENSIGHT BIOLOGICS S.A.
Profile
Sissel Rodahl is currently the Senior Vice President-Commercial Operations at Gensight Biologics SA since 2022.
Prior to this, she worked as Vice President at Novartis Gene Therapies, Inc. from 2018 to 2022.
She completed her graduate degree from the University of Oslo and her undergraduate degree from Engineering College.
Sissel Rodahl active positions
| Companies | Position | Start |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Corporate Officer/Principal | 2022-01-30 |
Former positions of Sissel Rodahl
| Companies | Position | End |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 2022-01-31 |
Training of Sissel Rodahl
| University of Oslo | Graduate Degree |
| Engineering College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Sissel Rodahl
